125 related articles for article (PubMed ID: 9073026)
21. Increased CSF cortisol in AD is a function of APOE genotype.
Peskind ER; Wilkinson CW; Petrie EC; Schellenberg GD; Raskind MA
Neurology; 2001 Apr; 56(8):1094-8. PubMed ID: 11320185
[TBL] [Abstract][Full Text] [Related]
22. Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4.
Mulder M; Ravid R; Swaab DF; de Kloet ER; Haasdijk ED; Julk J; van der Boom JJ; Havekes LM
Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):198-203. PubMed ID: 9772023
[TBL] [Abstract][Full Text] [Related]
23. Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease.
Varges D; Jung K; Gawinecka J; Heinemann U; Schmitz M; von Ahsen N; Krasnianski A; Armstrong VW; Zerr I
J Alzheimers Dis; 2011; 23(4):717-26. PubMed ID: 21157024
[TBL] [Abstract][Full Text] [Related]
24. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
Cui T; Zhou X; Jin W; Zheng F; Cao X
Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
[TBL] [Abstract][Full Text] [Related]
25. APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42.
Prince JA; Zetterberg H; Andreasen N; Marcusson J; Blennow K
Neurology; 2004 Jun; 62(11):2116-8. PubMed ID: 15184629
[TBL] [Abstract][Full Text] [Related]
26. Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.
Johansson P; Almqvist EG; Bjerke M; Wallin A; Johansson JO; Andreasson U; Blennow K; Zetterberg H; Svensson J
J Alzheimers Dis; 2017; 59(3):1017-1026. PubMed ID: 28697566
[TBL] [Abstract][Full Text] [Related]
27. CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease.
Tapiola T; Lehtovirta M; Ramberg J; Helisalmi S; Linnaranta K; Riekkinen P; Soininen H
Neurology; 1998 Jan; 50(1):169-74. PubMed ID: 9443475
[TBL] [Abstract][Full Text] [Related]
28. Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients.
Terrisse L; Poirier J; Bertrand P; Merched A; Visvikis S; Siest G; Milne R; Rassart E
J Neurochem; 1998 Oct; 71(4):1643-50. PubMed ID: 9751198
[TBL] [Abstract][Full Text] [Related]
29. Association of the apolipoprotein E epsilon4 allele with late-onset depression.
Rigaud AS; Traykov L; Caputo L; Coste J; Latour F; Couderc R; Moulin F; Boller F; Forette F
Neuroepidemiology; 2001 Oct; 20(4):268-72. PubMed ID: 11684904
[TBL] [Abstract][Full Text] [Related]
30. Cerebrospinal fluid lipoprotein delivery to human neuronal cells is increased in Alzheimer's disease and is dependent on apoE monomer concentration.
Bassett CN; Swift LL; Montine KS; Markesbery WR; Montine TJ
J Alzheimers Dis; 2002 Feb; 4(1):19-30. PubMed ID: 12214015
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein E epsilon4 allele frequency in vascular dementia.
Davidson Y; Gibbons L; Purandare N; Byrne J; Hardicre J; Wren J; Payton A; Pendleton N; Horan M; Burns A; Mann DM
Dement Geriatr Cogn Disord; 2006; 22(1):15-9. PubMed ID: 16645276
[TBL] [Abstract][Full Text] [Related]
32. Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.
Zimetti F; Caffarra P; Ronda N; Favari E; Adorni MP; Zanotti I; Bernini F; Barocco F; Spallazzi M; Galimberti D; Ricci C; Ruscica M; Corsini A; Ferri N
J Alzheimers Dis; 2017; 55(1):315-320. PubMed ID: 27662294
[TBL] [Abstract][Full Text] [Related]
33. Baseline CSF/Serum-Ratio of Apolipoprotein E and Rate of Differential Decline in Alzheimer's Disease.
Schmidt C; Gerlach N; Schmitz M; Thom T; Kramer K; Friede T; Zerr I
J Alzheimers Dis; 2015; 48(1):189-96. PubMed ID: 26401939
[TBL] [Abstract][Full Text] [Related]
34. Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease.
Combarros O; García-Román M; Fontalba A; Fernández-Luna JL; Llorca J; Infante J; Berciano J
Dement Geriatr Cogn Disord; 2003; 15(3):151-4. PubMed ID: 12584430
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry.
Merched A; Serot JM; Visvikis S; Aguillon D; Faure G; Siest G
FEBS Lett; 1998 Mar; 425(2):225-8. PubMed ID: 9559653
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E polymorphism and susceptibility to early- and late-onset sporadic Alzheimer's disease in Hokkaido, the northern part of Japan.
Nunomura A; Chiba S; Eto M; Saito M; Makino I; Miyagishi T
Neurosci Lett; 1996 Mar; 206(1):17-20. PubMed ID: 8848271
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein E: depressive illness, depressive symptoms, and Alzheimer's disease.
Holmes C; Russ C; Kirov G; Aitchison KJ; Powell JF; Collier DA; Lovestone S
Biol Psychiatry; 1998 Feb; 43(3):159-64. PubMed ID: 9494696
[TBL] [Abstract][Full Text] [Related]
38. Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.
Kim HC; Kim DK; Choi IJ; Kang KH; Yi SD; Park J; Park YN
Psychiatry Clin Neurosci; 2001 Apr; 55(2):115-20. PubMed ID: 11285089
[TBL] [Abstract][Full Text] [Related]
39. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
[TBL] [Abstract][Full Text] [Related]
40. Combined effect of apolipoprotein e genotype and past fertility on age at onset of Alzheimer's disease in women.
Corbo RM; Gambina G; Ulizzi L; Monini P; Broggio E; Rosano A; Scacchi R
Dement Geriatr Cogn Disord; 2007; 24(2):82-5. PubMed ID: 17565217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]